Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 2138440-82-9
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Yttrium(III) 2-ethylhexanoate has been used for research in nanotechnology based applications.
Thalidomide-NH-PEG3-propionic acid serves as a bifunctional linker for targeted conjugation, combining the pharmacophoric thalidomide moiety with a PEG3 spacer and carboxylic acid handle. The propionic acid group enables facile amide coupling, while the PEG3 segment enhances solubility and reduces aggregation. This reagent facilitates site-specific bioconjugation in antibody-drug conjugates and PROTACs, offering improved stability and predictable conjugation efficiency in aqueous media.
|
GHS Pictogram :
|
GHS No : GHS08
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H361
|
|
|
Precautionary Statements : P280-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: